The difference was accounted for by a 3–9-fold increase in CD4+CXCR5+ICOShigh circulating Tfh cells in 7of the 19 RA patients between anti-CCP antibody-positive group and anti-CCP antibody-negative group (Figure 2(d)). The gene discussed is CXCR5; the disease is rheumatoid arthritis.